A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa — Marie Onyamboko (2019) | RDL Network
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa
Antimicrobial Agents and Chemotherapy 64(3)
Article 2019 English
Authors
MO
Marie Onyamboko
RH
Richard M. Hoglund
SL
Sue J. Lee
Abstract
1 min read
Artemether-lumefantrine antimalarial efficacy in pregnancy could be compromised by reduced drug exposure. Population-based simulations suggested that therapeutic efficacy would be improved if the treatment duration was increased.
Rose McGready, Saw Oo Tan, Elizabeth A. Ashley, Mupawjay Pimanpanarak, Jacher Viladpai-nguen, Lucy Phaiphun, Katja Wüstefeld, M. Barends, Natthapon Laochan, Lily Keereecharoen, Niklas Lindegårdh, Pratap Singhasivanon, Sir Nicholas White, François Nosten
Joel Tärning, Rose McGready, Niklas Lindegårdh, Elizabeth A. Ashley, Mupawjay Pimanpanarak, Benjamas Kamanikom, Anna Annerberg, Nicholas Day, Kasia Stepniewska, Pratap Singhasivanon, Sir Nicholas White, François Nosten
Robert Hutagalung, Lucy Paiphun, Elizabeth A. Ashley, Rose McGready, Alan Brockman, Kaw L Thwai, Pratap Singhasivanon, T. Jelinek, Sir Nicholas White, François Nosten
Elizabeth A. Ashley, Kasia Stepniewska, Niklas Lindegårdh, Rose McGready, Anna Annerberg, Robert Hutagalung, Thida Singtoroj, Gilvary Hla, Al Brockman, Stéphane Proux, Jahser Wilahphaingern, Pratap Singhasivanon, Sir Nicholas White, François Nosten
Discussion(0)
No comments yet. Be the first to comment.